Further research for consideration in 'the A2 milk case' [1]

European Journal of Clinical Nutrition

Volumn 60, Issue 7, 2006, Pages 921-924

  Allison, A J ^a   Clarke, Andrew J ^a  

^a A2 Corporation Limited   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CASEIN; BETA CASEIN A1; BETA CASOMORPHINE 7; BETA CASOMORPHINE DERIVATIVE; CASEIN; CHOLESTEROL; MILK PROTEIN; UNCLASSIFIED DRUG;

ANTIBODY DETECTION; APNEA; ARTIFICIAL MILK; ATHEROSCLEROSIS; AUTISM; CELLULAR IMMUNITY; CHILD NUTRITION; CHOLESTEROL BLOOD LEVEL; DIABETOGENESIS; DIET SUPPLEMENTATION; DIETARY INTAKE; FOOD ANALYSIS; FOOD COMPOSITION; FOUNDER EFFECT; GENE FREQUENCY; GLUTEN FREE DIET; HUMAN; IMMUNOREACTIVITY; INSULIN DEPENDENT DIABETES MELLITUS; ISCHEMIC HEART DISEASE; LETTER; NEUROLOGIC DISEASE; NONHUMAN; NUTRIENT CONTENT; NUTRITIONAL ASSESSMENT; PATHOPHYSIOLOGY; PROTEIN ANALYSIS; PROTEIN METABOLISM; SCHIZOPHRENIA;

ANIMALS; CASEINS; CORONARY DISEASE; DIABETES MELLITUS, TYPE 1; ENDORPHINS; HUMANS; MILK; PEPTIDE FRAGMENTS;

EID: 33745684530     PISSN: 09543007     EISSN: 14765640     Source Type: Journal    
DOI: 10.1038/sj.ejcn.1602276     Document Type: Letter

References (30)

1. Australian Broadcasting Corporation (2003) White mischief Transcript available atwww.abc.net.au/4corners/content/2003/transcripts/s820943.htm.
2. Banks WA, Kastin AJ (1987). Saturable transport of peptides across the blood-brain barrier. Life Sci 41 (11), 1319-1338.
3. Beales PE, Elliott RB, Flohe S, Kolb H, Hill JP, Pozzilli P et al. (2002). A multi-centre, blinded international trial of the effect of A1 and A2 beta-casein variants on diabetes incidence in two rodent models of spontaneous type 1 diabetes. Diabetologia 45 (9), 1240-1246. [e-pub 2002 Jul 19].
4. Birgisdottir BE, Hill JP, Harris DP, Thorsdotter A (2002). Variation in consumption of cow milk proteins and lower incidence of Type 1 diabetes in Iceland vs the other 4 Nordic countries. Diab Nutr Metab 15, 240-245.
5. Cade R, Privette M, Fregly M, Rowland N, Sun Z, Zele V et al. (2000). Autism and Schizophrenia: Intestinal Disorders. Nutritional Neuroscience March 2000.
6. Chabance B, Marteau P, Rambaud JC, Migliore (1998). Casein peptide release and passage to the blood in humans during digestion of milk or yogurt. Biochimie 80 (2), 155-165.
7. Channel 7 (2003). Today Tonight, Australia. Wonder Milk. Helen Wellings, July 2003. Transcript available at http://seven.com.au/todaytonight/ results/A2%20Milk/0.
8. Cone DH (2002). Secret memo reveals Fonterra alarm. National Business Review p14: Nov 1.
9. FitzGerald RJ, Meisel H (2000). Milk protein-derived peptide inhibitors of angiotensin-I-converting enzyme. Br J Nutr 84 (Suppl 1), S33-S37.
10. Herrera-Marschitz M, Terenius L, Grehn L, Ungerstedt U (1989). Rotational behaviour produced by intranigral injections of bovine and human beta-casomorphins in rats. Psychopharmacology (Berlin) 99 (3), 357-361.
11. Jinsmaa Y, Yoshikawa M (1999). Enzymatic release of neo-casomorphin and beta casomorphin from bovine beta-casein. Peptides V 20 (8), 957-962.
12. Knivsberg AM, Reichelt KL, Hoien T, Nodland M (2002). A randomised, controlled study of dietary intervention in autistic syndromes. Nutr Neurosci 5 (4), 251-261.
13. Meisel H, FitzGerald RJ (2000). Opioid peptides encrypted in intact milk protein sequences. Br J Nutr 83 (Suppl 1), S27-S31.
14. Nyberg F, Lieberman H, Lindstrom LH, Lyrenas S, Koch G, Terenius L (1989). Immunoreactive beta-casomorphin-8 in cerebrospinal fluid from pregnant and lactating women: Correlation with plasma levels. J Clin Endocrinol Metab 68 (2), 283-289.
15. Padberg S, Schumm-Draeger PM, Petzoldt R, Becker F, Federlin K (1999). Article in German.) [The significance of A1 and A2 antibodies against beta-casein in type-1 diabetes mellitus]. Dtsch Med Wochenschr 124 (50), 1518-1521.
16. Panksepp J, Normansell L, Siviy S, Rossi 3rd J, Zolovick AJ (1984). Casomorphins reduce separation distress in chicks. Peptides 5 (4), 829-831.
17. Pozzilli P (1999). β-casein in cow's milk: A major anit-gentic determinant for type 1 diabetes? J Endocrinol Invest 22, 562-567.
18. Scott FW (1996). Food induced type 1 diabetes in the BB rat. Diabetes Metab Rev 12, 341-359.
19. Shah N (2000). Effects of Milk-derived bioactives: An overview. Br J Nutr 84 (Suppl. 1), S3-310.
20. Singh M, Rosen CL, Chang KJ, Haddad GG (1989). Plasma beta-casomorphin-7 immunoreactive peptide increases after milk intake in newborn but not in adult dogs. Pediatr Res 26 (1), 34-38.
21. Siow RC, Richards JP, Pedley KC, Leake DS, Mann GE (1999). Vitamin C protects human vascular smooth muscle cells against apoptosis induced by moderately oxidized LDL containing high levels of lipid hydroperoxides. Arterioscler Thromb Vasc Biol 19 (10), 2387-2394.
22. Steinerova A, Racek J, Rajdl D, Stožicky F, Rokyta Z, Trefil L et al. (2004) Letter to the Editor V 173: 1, 147-148.
23. Steinerova A, Racek J, Stozicky F, Tatzber F (1999). Autoantibodies against oxidised LDL in the first phase of life. Clin Chem Lab Med 37 (9), 213-217.
24. Steinerova A, Racek J, Stozicky F, Tatzber F (2001). Autoantibodies against oxidised LDL in infants. Clin Chem 47 (6), 1137-1138.
25. Sun Z, Zhang Z, Ang X, Cade R, Elmir Z, Fegly M (2003). Relation of beta-casomorphin to Apnea in Sudden Infant Death Syndrome. Peptides 24 (6), 937-943.
26. Svedberg J, de Haas J, Leimenstoll G, Paul F, Teschemacher H (1985). Demonstration of β-casomorphin immunoreactive materials in In vitro digests of bovine milk and in small intestine contents after bovine milk ingestion in adult humans. Peptides V 6, 825-830.
27. Tailford KA, Berry CL, Thomas AC, Campbell JH (2003). A casein variant in cow's milk is atherogenic. Atherosclerosis 170 (1), 13-19.
28. Torreilles J, Guerin MC (1995). Casein-derived peptides promote peroxidase-dependent oxidation of human blood low-density lipoproteins. CR Seances Soc Biol Fil 189 (5), 933-942.
29. Umbach M, Teschemacher H, Praetorius K, Hirschhauser R, Bostedt H (1985). Demonstration of a beta-casomorphin immunoreactive material in the plasma of newborn calves after milk intake. Regul Pept 12 (3), 223-230.
30. Wasmuth HE, Rosenbauer J, Elliott RB, McLachlan C, Erhardt G, Giani G et al. (1999). β-casein A1 consumption and incidence of Type 1 Diabetes in Germany. Kongress der Europäischen Diabetesgesellschaft vom 28, 30.09.1999 in Brüssel/Belgien.